KG Bio
Bringing Biologics Medical Innovation to International Market
Jakarta · Founded 2015 · $55.0M raised
- Headquarters
- Jakarta
- Founded
- 2015
- Business Model
- B2B
- Website
- kg-biologics.com
- Total Funding
- $55.0M
- Last Round
- $55.0M Series CJan 2021
- Rounds
- 1
About
KGbio (PT Kalbe Genexine Biologics) is a clinical-stage biotechnology company backed by Kalbe Farma of Indonesia and Genexine of South Korea, formed as a joint venture in 2015. It focuses on in-licensing and out-licensing biologics and biosimilars in oncology and other high-specialty therapeutic areas, and also provides cGMP contract development and manufacturing services as a pioneer of biopharmaceutical CDMO work in Indonesia.
Summary
KG Bio is a Life Sciences company based in Jakarta, founded in 2015. It has raised $55.0M in total across 1 round, most recently a $55.0M Series C round in Jan 2021. Investors include General Atlantic.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.